Suppr超能文献

吲哚洛尔,一种对血管β-肾上腺素能受体具有部分激动作用的β受体阻滞剂。

Indenolol, a beta-blocker with partial agonism at vascular beta-adrenoceptors.

作者信息

Taddei S, Pedrinelli R, Salvetti A

机构信息

Hypertension Unit, University of Pisa, Italy.

出版信息

Clin Pharmacol Ther. 1989 Nov;46(5):560-5. doi: 10.1038/clpt.1989.186.

Abstract

Intrinsic sympathomimetic activity may attenuate some effects caused by treatment with beta-adrenoceptor blockers. Indenolol is a nonselective beta-adrenoceptor antagonist whose sympathomimetic properties have been shown in vitro but not in human beings. We infused indenolol cumulatively (5, 15, and 50 micrograms/100 ml tissue per minute for 15 minutes each, preceded by an infusion of saline solution) into the brachial arteries of nine hypertensive patients. Forearm blood flow (venous plethysmography), mean arterial pressure, and heart rate were monitored. During infusion at 5 micrograms/100 ml tissue per minute, forearm blood flow did not change, but it did increase dose-dependently at the greater infusion rates. This action was determined to be mediated by beta-adrenoceptor stimulation because propranolol (10 micrograms/100 ml tissue per minute for 15 minutes), given before treatment and then concomitantly with indenolol, abolished it (n = 5). Indenolol vasodilated forearm arterioles and this effect was antagonized by beta-blockade, thus demonstrating vascular intrinsic sympathomimetic activity. This property may contribute to its therapeutic action in human beings.

摘要

内在拟交感活性可能会减弱β肾上腺素能受体阻滞剂治疗所引起的某些效应。茚诺洛尔是一种非选择性β肾上腺素能受体拮抗剂,其拟交感特性已在体外得到证实,但在人体中尚未得到证实。我们对9例高血压患者的肱动脉进行了茚诺洛尔的累积输注(每分钟5、15和50微克/100毫升组织,每次输注15分钟,之前先输注生理盐水)。监测前臂血流量(静脉体积描记法)、平均动脉压和心率。在以每分钟5微克/100毫升组织的速率输注期间,前臂血流量没有变化,但在更高的输注速率下,它确实呈剂量依赖性增加。这种作用被确定是由β肾上腺素能受体刺激介导的,因为在治疗前给予普萘洛尔(每分钟10微克/100毫升组织,持续15分钟),然后与茚诺洛尔同时给予,可消除这种作用(n = 5)。茚诺洛尔使前臂小动脉血管舒张,这种效应被β受体阻滞所拮抗,从而证明了血管内在拟交感活性。这种特性可能有助于其在人体中的治疗作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验